Table 1.

Patient Characteristics prior to Lung Transplantation

Clinical Parameter		Mean ± SD or n (%)
		Entire Cohort (n=51)	CF (n=31)	Pulmonary HTN (n=8)	GVHD (n=7)	Pulmonary Fibrosis (n=3)	Other (n=2)
	Gender	Female	26 (51)	18 (58)	4 (50)	1 (14)	1 (33)	1 (50)
	Male	25 (49)	13 (42)	4 (50)	6 (86)	2 (67)	1 (50)
Age at transplant, y		14.7 ± 4.8	15.7 ± 4.4	11.9 ± 5.5	16.2 ± 2.6	14.3 ± 4.8	5.6 ± 0.1
Race/Ethnicity	White	36 (71)	23 (74)	4 (50)	5 (71)	3 (100)	1 (50)
	Black	2 (4)	0	1 (12.5)	1 (14)	0	0
	Hispanic	5 (10)	3 (10)	1 (12.5)	1 (14)	0	0
	Asian	2 (4)	0	1 (12.5)	0	0	1 (50)
	Other	6 (12)	5 (16)	1 (12.5)	0	0	0
FEV1, % predicted		32 ± 11	35.8 ± 8.6	—	19.0 ± 7.3	20.5 ± 10.6	—
Height Z-score		−1.1 ± 1.4	−1.1 ± 1.1	0.2 ± 1.3	−2.0 ± 1.7	−2.5 ± 0.7	−3.2 ± 1.2
BMI Z-score		−0.8 ± 1.3	−1.0 ± 1.1	0.4 ± 1.2	−1.4 ± 1.2	−0.8 ± 2.0	−0.5 ± 0.2
Laboratory evaluation	25(OH)D, ng/mL	29.7 ± 12.6	31.7 ± 9.9	17.9 ± 6.8	39.3 ± 19.9	20.0 ± 15.5	23.4 ± 4.7
	PTH, ng/mL	37.2 ± 3.1	33.1 ± 19.0	81.0 ± 55	22.4 ± 34	27.8 ± 14	30 ± 4.9
	HbA1c, %	6.3 ± 1.4	6.6 ± 1.5	5.4	5.4 ± 0.8	5.7	—
BMD Z-score	Lowest site	−2.2 ± 1.4	−1.8 ± 1.1	−1.2 ± 2.2	−3.4 ± 2.2	−2.9 ± 0.5	−2.8
	Spine	−1.6 ± 1.1	−1.7 ± 1.1	−1.0 ± 2.5	−2.0 ± 1.0	−1.4	−2.2
	Hip	−1.8 ± 1.2	−1.4 ± 0.8	−1.0 ± 1.9	−2.7 ± 2.6	−2.9 ± 0.5	−2.8
Patients with Fractures	Pre-transplant	9 (18)	4 (13)	1 (12.5)	2 (29)	1 (33)	1 (50)
	Post-transplant	15 (29)	9 (29)	3 (37.5)	1 (14)	1 (33)	1 (50)